Govt sets allocation of Covid drug Tocilizumab to states amid shortage
Tocilizumab is an imported drug manufactured by Roche, which is being prescribed for treatment of some Covid-19 patients under certain conditions
Fresh limited stock of this drug has now been imported and is available with the lone marketer company Cipla Ltd, the govt says
As novel coronavirus cases surge in the country, the demand for Covid-19 medicines such as Remdesivir, Fabiflu, and Tocilizumab is increasing too. Taking note of the shortage, the Union Health Ministry on Wednesday allocated a fresh stock of imported drug Tocilizumab, used for treatment of Covid-19 among the states.